Trillium Therapeutics (TR) Stock Price, News & Analysis

Company Overview

Troubadour Resources Inc. is a North American mineral acquisition and exploration company focused on the development of quality critical metal properties that are drill-ready with high-upside and expansion potential. Based in Vancouver, BC British Columbia, Troubadour's portfolio of strategic properties provides target-rich diversification and includes the Senneville Copper-Gold VMS project in Quebec, and the Amarillo Copper Porphyry and Texas Silver-Gold Projects in BC British Columbia. Troubadour trades on the TSX Venture Exchange under the symbol 'TR' and the OTC Market under the symbol 'TROUF'.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 49,075 shs
• Average Volume: 99,071 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Manufacturing
• Industry: Sugar And Confectionery Products
• Sub-Industry: Food Products
• Current Symbol: TSE:TR
• CIK: N/A
• Web: www.trilliumtherapeutics.com
• Phone: +1-416-5950627
• Fax: N/A
• Employees: 2,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A